These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 19209471)
1. Bisphosphonates and metabolic bone disease in the ICU. Hollander JM; Mechanick JI Curr Opin Clin Nutr Metab Care; 2009 Mar; 12(2):190-5. PubMed ID: 19209471 [TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates in the treatment of metabolic bone diseases. Arantes HP; Silva AG; Lazaretti-Castro M Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):206-12. PubMed ID: 20485910 [TBL] [Abstract][Full Text] [Related]
3. [Progress and problems in oral bisphosphonate]. Takeuchi Y Clin Calcium; 2014 Jan; 24(1):27-33. PubMed ID: 24369277 [TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients. Jobke B; Milovanovic P; Amling M; Busse B Bone; 2014 Feb; 59():37-43. PubMed ID: 24211427 [TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates and osteonecrosis: potential treatment or serious complication? Goytia RN; Salama A; Khanuja HS Orthop Clin North Am; 2009 Apr; 40(2):223-34. PubMed ID: 19358907 [TBL] [Abstract][Full Text] [Related]
6. [Inflammation of the jaws during treatment with bisphosphonates]. Bartl R Dtsch Med Wochenschr; 2011 Oct; 136(41):2109-10. PubMed ID: 21971888 [No Abstract] [Full Text] [Related]
7. Long-term use of bisphosphonates in osteoporosis. Watts NB; Diab DL J Clin Endocrinol Metab; 2010 Apr; 95(4):1555-65. PubMed ID: 20173017 [TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages. Roelofs AJ; Thompson K; Ebetino FH; Rogers MJ; Coxon FP Curr Pharm Des; 2010; 16(27):2950-60. PubMed ID: 20722616 [TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates prevent experimental vascular calcification: Treat the bone to cure the vessels? Persy V; De Broe M; Ketteler M Kidney Int; 2006 Nov; 70(9):1537-8. PubMed ID: 17051257 [TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates for Paget's disease of bone in adults. Corral-Gudino L; Tan AJ; Del Pino-Montes J; Ralston SH Cochrane Database Syst Rev; 2017 Dec; 12(12):CD004956. PubMed ID: 29192423 [TBL] [Abstract][Full Text] [Related]
11. Underlying Mechanisms and Therapeutic Strategies for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ). Endo Y; Kumamoto H; Nakamura M; Sugawara S; Takano-Yamamoto T; Sasaki K; Takahashi T Biol Pharm Bull; 2017; 40(6):739-750. PubMed ID: 28566618 [TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients. Kyrgidis A; Triaridis S; Vahtsevanos K; Antoniades K Expert Rev Anticancer Ther; 2009 Aug; 9(8):1125-34. PubMed ID: 19671032 [TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapies to manage bone loss-associated diseases: a quest for the perfect benefit-to-risk ratio. Valverde P Curr Med Chem; 2008; 15(3):284-304. PubMed ID: 18288984 [TBL] [Abstract][Full Text] [Related]